Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/186150
Pancreatic Organoids for Regenerative Medicine and Cancer Research
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
In recent years, the development of ex vivo organoid cultures has gained substantial attention as a model to study regenerative medicine and diseases in several tissues. Diabetes and pancreatic ductal adenocarcinoma (PDAC) are the two major devastating diseases affecting the pancreas. Suitable models for regenerative medicine in diabetes and to accurately study PDAC biology and treatment response are essential in the pancreatic field. Pancreatic organoids can be generated from healthy pancreas or pancreatic tumors and constitute an important translational bridge between in vitro and in vivo models. Here, we review the rapidly emerging field of pancreatic organoids and summarize the current applications of the technology to tissue regeneration, disease modelling, and drug screening.
Subject (English)
Citation
Citation
CASAMITJANA, Joan, ESPINET, Elisa and ROVIRA, Meritxell. Pancreatic Organoids for Regenerative Medicine and Cancer Research. Frontiers in Cell and Developmental Biology. 2022. Vol. 10. ISSN 2296-634X. [consulted: 7 of June of 2026]. Available at: https://hdl.handle.net/2445/186150